VREX

Upcoming Investor Conferences: Varex Imaging Corporation will present at the Oppenheimer's 35th Annual MedTech & Services Virtual Conference on March 17, 2025, and the Sidoti Small Cap Virtual Conference on March 19, 2025. Webcast links are provided for both events.

Company Overview: Varex Imaging is a leading manufacturer of X-ray imaging components with over 70 years of innovation, serving medical, industrial, and security imaging markets globally, employing around 2,300 people across North America, Europe, and Asia.

Stock Performance: Varex Imaging's shares fell 19% after the company reported first-quarter revenue of $200 million, which was below Wall Street's expectation of $201.7 million, despite a slight earnings per share beat.

Future Outlook: The company provided cautious guidance for the second quarter of fiscal year 2025, projecting revenues between $200 million and $215 million, while CEO Sunny Sanyal noted solid demand in both Medical and Industrial segments.

Q1 2025 Performance: Varex Imaging reported a 5% year-over-year revenue growth to $200 million, with strong demand in both Medical and Industrial segments, particularly in China. Gross margin improved to 35%, driven by a favorable product mix and operational efficiencies.

Outlook and Concerns: For Q2 2025, the company anticipates revenues between $200 million and $215 million, while expressing caution regarding potential tariff changes and macroeconomic uncertainties that could impact future performance.

Financial Performance: Varex Imaging Corporation reported $200 million in revenues for Q1 FY25, a 5% increase year-over-year, with non-GAAP net earnings of $0.07 per diluted share and cash flow from operations at $10 million.

Outlook and Guidance: The company anticipates continued solid demand across its Medical and Industrial segments, projecting revenues between $200 million and $215 million for Q2 FY25, with expected non-GAAP net earnings per diluted share ranging from $0.05 to $0.20.

Financial Performance: Varex Imaging Corporation reported a revenue of $200 million for Q1 FY2025, marking a 5% increase year-over-year, with a GAAP net loss of $0.01 per diluted share and non-GAAP net earnings of $0.07 per diluted share. The company expects continued solid demand in both Medical and Industrial segments for the upcoming quarter.

Outlook and Guidance: For Q2 FY2025, Varex anticipates revenues between $200 million and $215 million, with non-GAAP net earnings per diluted share projected to range from $0.05 to $0.20, while emphasizing that these forecasts are subject to various uncertainties.

Cargo Inspection Orders: Varex Imaging Corporation has received approximately $14 million in orders for its newly launched non-intrusive cargo inspection systems, the VXP-6 Portal and VXM-6 Mobile systems, aimed at enhancing security at ports and borders.

Company Overview: Varex Imaging is a leading manufacturer of X-ray imaging components with over 70 years of experience, providing solutions for medical, industrial, and security applications globally.

Upcoming Investor Conferences: Varex Imaging Corporation will participate in the BTIG MedTech Conference on February 12, 2025, and the B. Riley Securities Precision Oncology & Radiopharma Conference on February 28, 2025, both featuring one-on-one meetings.

Company Overview: Varex Imaging is a leading manufacturer of X-ray imaging components with over 70 years of innovation, serving medical, industrial, and security imaging markets globally, and employing around 2,300 people across North America, Europe, and Asia.

Meta Platforms' Strong Performance: Meta Platforms, Inc. reported fourth-quarter revenue of $48.39 billion and earnings of $8.02 per share, surpassing analyst expectations, leading to a 2.2% increase in pre-market trading.

Market Movements: Several stocks experienced significant changes in pre-market trading, with Alterity Therapeutics gaining 105% while CARGO Therapeutics saw a drastic drop of 74.3% after discontinuing a study.

Earnings Announcement: Varex Imaging Corporation will report its unaudited financial results for Q1 of fiscal year 2025 on February 6, 2025, followed by a conference call at 3:00 pm Mountain Time.

Company Overview: Varex Imaging is a leading manufacturer of X-ray imaging components with over 70 years of innovation, serving medical, industrial, and security imaging markets globally.

Company Presentation Announcement: Varex Imaging Corporation will present at the CJS Securities 25th Annual New Ideas for the New Year Virtual Conference on January 14, 2025, at 2:20pm ET, with a webcast available on their website.

About Varex Imaging: Varex is a leading manufacturer of X-ray imaging components, serving medical, industrial, and security applications, with a history of innovation spanning 75 years and approximately 2,300 employees globally.

Varex Imaging Corporation's Offering: Varex Imaging Corporation has successfully closed a private offering of $125 million in senior secured notes due 2027, which will help in the partial repayment of convertible notes due in June 2025 and maintain availability under their revolving credit facility.

Company Overview: Varex Imaging is a leading manufacturer of X-ray imaging components with a history of 75 years, providing products for medical, industrial, and security imaging applications, and employs around 2,300 people globally.

Private Offering Announcement: Varex Imaging Corp. has priced a private offering of $125 million in 7.875 percent senior notes, due October 15, 2027, to fund the repayment or repurchase of outstanding convertible notes due June 2025.

Stock Performance: The company's stock is currently trading at $15, reflecting a decrease of 0.92 percent on the Nasdaq.

Private Offering Announcement: Varex Imaging Corporation has priced a private offering of $125 million in senior secured notes due October 15, 2027, with plans to use the proceeds for repaying outstanding Convertible Notes and terminating its Equipment Credit Agreement.

Forward-Looking Statements: The announcement includes forward-looking statements regarding the closing of the offering, use of proceeds, and potential risks that could affect Varex's actual results compared to expectations.

New Offering Announcement: Varex Imaging Corporation has initiated an offering of $125 million in 7.875 percent senior secured notes due October 15, 2027, supplementing its existing $300 million offering of the same notes.

Use of Proceeds and Stock Performance: The funds will be used to partially repay outstanding convertible notes due June 2025, while Varex's stock is currently trading at $15.01, reflecting a 2.81 percent decrease on the Nasdaq.

Private Offering Announcement: Varex Imaging Corporation has initiated a private offering of $125 million in senior secured notes due October 15, 2027, to partially repay existing Convertible Notes and secure funding for its operations.

Investment Risks and Forward-Looking Statements: The offering is subject to market conditions and involves risks that could affect the company's financial performance, including changes in market demand and competition, as well as regulatory challenges.

Annual Meeting Announcement: Varex Imaging Corporation will hold its 2025 Annual Meeting of Stockholders virtually on February 13, 2025, at 4:30 pm Mountain Time, with stockholders of record as of December 16, 2024, eligible to vote.

Company Overview: Varex Imaging is a leading manufacturer of X-ray imaging components, serving medical, industrial, and security applications, and employs approximately 2,300 people globally.

Introduction of New Products: Varex Imaging Corporation has launched the LUMEN HD and LUMEN HD Pro digital radiography detectors, designed to enhance healthcare imaging with features like reliability, speed, ease of use, configurability, and affordability.

Company Background: Varex Imaging is a prominent manufacturer of X-ray imaging components with over 70 years of experience, providing innovative solutions for medical, industrial, and security imaging applications globally.

Stock Performance Overview: VREX's stock has a 52-week low of $10.19 and a high of $21.50, with the last trade recorded at $15.49.

Author's Perspective Disclaimer: The opinions expressed in the article are solely those of the author and do not necessarily reflect the views of Nasdaq, Inc.

Financial Performance: Varex Imaging Corporation reported Q4 FY24 revenues of $206 million, a 10% decrease year-over-year, with a GAAP net loss of $(1.22) per diluted share, while non-GAAP net earnings were $0.19 per diluted share. For the fiscal year 2024, total revenues were $811 million, also reflecting a decline from the previous year.

Future Outlook: The company anticipates Q1 FY25 revenues between $195 million and $215 million, with expected non-GAAP net earnings per diluted share ranging from -$0.05 to $0.10, as it continues to focus on technological advancements in its Industrial segment.

Upcoming Earnings Reports: Major companies set to report earnings after the market closes on Tuesday include Star Bulk Carriers Corp., Golub Capital BDC, Powell Industries, and Keysight Technologies.

Additional Earnings Releases: Other firms expected to announce their earnings include AZEK, DLB, LZB, QFIN, SNEX, VREX, XP, and ZTO.